 | • レポートコード：MRC23Q36234 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の眼科用機器/医薬品市場について調査・分析し、世界の眼科用機器/医薬品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（眼科機器、眼科用医薬品）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Zeiss、Haag Streit、Topcon、Nidek、Essilor、Ziemer、Canon、Gulden Ophthalmics、Optovue、Quest Medical、Phoenix DeVentures、EyeKon Medical、FCI Ophthalmics、Atrion、Sterimedix、OPIA、IRIDEX、Jardon Eye Prosthetics、Santen Pharmaceutical、Bausch Health、Takeda、Novartis、Genentech、Allergan、Sun Pharmaceutical Industries、Actavis Generics、Regeneron Pharmaceuticals、Pfizer、Johnson and Johnson、Bausch and Lombなどが含まれています。 世界の眼科用機器/医薬品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、眼科用機器/医薬品市場規模を推定する際に考慮しました。本レポートは、眼科用機器/医薬品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、眼科用機器/医薬品に関するビジネス上の意思決定に役立てることを目的としています。 ・眼科用機器/医薬品市場の概要 - 眼科用機器/医薬品のタイプ別セグメント - 世界の眼科用機器/医薬品市場規模：タイプ別分析（眼科機器、眼科用医薬品） - 眼科用機器/医薬品の用途別セグメント - 世界の眼科用機器/医薬品市場規模：用途別分析（病院、クリニック、その他） - 世界の眼科用機器/医薬品市場規模予測（2018年-2029年） ・眼科用機器/医薬品市場の成長トレンド - 眼科用機器/医薬品の地域別市場規模（2018年-2029年） - 眼科用機器/医薬品市場ダイナミクス - 眼科用機器/医薬品の業界動向 - 眼科用機器/医薬品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：眼科機器、眼科用医薬品 - 世界の眼科用機器/医薬品のタイプ別市場規模（2018年-2023年） - 世界の眼科用機器/医薬品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界の眼科用機器/医薬品の用途別市場規模（2018年-2023年） - 世界の眼科用機器/医薬品の用途別市場規模（2024年-2029年） ・眼科用機器/医薬品の地域別市場規模 - 北米の眼科用機器/医薬品市場規模（2018年-2029年） - アメリカの眼科用機器/医薬品市場規模（2018年-2029年） - ヨーロッパの眼科用機器/医薬品市場規模（2018年-2029年） - アジア太平洋の眼科用機器/医薬品市場規模（2018年-2029年） - 中国の眼科用機器/医薬品市場規模（2018年-2029年） - 日本の眼科用機器/医薬品市場規模（2018年-2029年） - 韓国の眼科用機器/医薬品市場規模（2018年-2029年） - インドの眼科用機器/医薬品市場規模（2018年-2029年） - オーストラリアの眼科用機器/医薬品市場規模（2018年-2029年） - 中南米の眼科用機器/医薬品市場規模（2018年-2029年） - 中東・アフリカの眼科用機器/医薬品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Zeiss、Haag Streit、Topcon、Nidek、Essilor、Ziemer、Canon、Gulden Ophthalmics、Optovue、Quest Medical、Phoenix DeVentures、EyeKon Medical、FCI Ophthalmics、Atrion、Sterimedix、OPIA、IRIDEX、Jardon Eye Prosthetics、Santen Pharmaceutical、Bausch Health、Takeda、Novartis、Genentech、Allergan、Sun Pharmaceutical Industries、Actavis Generics、Regeneron Pharmaceuticals、Pfizer、Johnson and Johnson、Bausch and Lomb ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Ophthalmic Devices and Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Ophthalmic Devices and Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Ophthalmic Devices and Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Ophthalmic Devices and Drugs in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Ophthalmic Devices and Drugs include Zeiss, Haag Streit, Topcon, Nidek, Essilor, Ziemer, Canon, Gulden Ophthalmics and Optovue, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Devices and Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Devices and Drugs.
The Ophthalmic Devices and Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Ophthalmic Devices and Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Devices and Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Zeiss
Haag Streit
Topcon
Nidek
Essilor
Ziemer
Canon
Gulden Ophthalmics
Optovue
Quest Medical
Phoenix DeVentures
EyeKon Medical
FCI Ophthalmics
Atrion
Sterimedix
OPIA
IRIDEX
Jardon Eye Prosthetics
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Segment by Type
Ophthalmic Devices
Ophthalmic Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Devices and Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Ophthalmic Devices
1.2.3 Ophthalmic Drugs
1.3 Market by Application
1.3.1 Global Ophthalmic Devices and Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Devices and Drugs Market Perspective (2018-2029)
2.2 Ophthalmic Devices and Drugs Growth Trends by Region
2.2.1 Global Ophthalmic Devices and Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ophthalmic Devices and Drugs Historic Market Size by Region (2018-2023)
2.2.3 Ophthalmic Devices and Drugs Forecasted Market Size by Region (2024-2029)
2.3 Ophthalmic Devices and Drugs Market Dynamics
2.3.1 Ophthalmic Devices and Drugs Industry Trends
2.3.2 Ophthalmic Devices and Drugs Market Drivers
2.3.3 Ophthalmic Devices and Drugs Market Challenges
2.3.4 Ophthalmic Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic Devices and Drugs Players by Revenue
3.1.1 Global Top Ophthalmic Devices and Drugs Players by Revenue (2018-2023)
3.1.2 Global Ophthalmic Devices and Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Ophthalmic Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ophthalmic Devices and Drugs Revenue
3.4 Global Ophthalmic Devices and Drugs Market Concentration Ratio
3.4.1 Global Ophthalmic Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Devices and Drugs Revenue in 2022
3.5 Ophthalmic Devices and Drugs Key Players Head office and Area Served
3.6 Key Players Ophthalmic Devices and Drugs Product Solution and Service
3.7 Date of Enter into Ophthalmic Devices and Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Devices and Drugs Breakdown Data by Type
4.1 Global Ophthalmic Devices and Drugs Historic Market Size by Type (2018-2023)
4.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2024-2029)
5 Ophthalmic Devices and Drugs Breakdown Data by Application
5.1 Global Ophthalmic Devices and Drugs Historic Market Size by Application (2018-2023)
5.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Ophthalmic Devices and Drugs Market Size (2018-2029)
6.2 North America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
6.4 North America Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmic Devices and Drugs Market Size (2018-2029)
7.2 Europe Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
7.4 Europe Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Devices and Drugs Market Size (2018-2029)
8.2 Asia-Pacific Ophthalmic Devices and Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Ophthalmic Devices and Drugs Market Size (2018-2029)
9.2 Latin America Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
9.4 Latin America Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Devices and Drugs Market Size (2018-2029)
10.2 Middle East & Africa Ophthalmic Devices and Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zeiss
11.1.1 Zeiss Company Detail
11.1.2 Zeiss Business Overview
11.1.3 Zeiss Ophthalmic Devices and Drugs Introduction
11.1.4 Zeiss Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.1.5 Zeiss Recent Development
11.2 Haag Streit
11.2.1 Haag Streit Company Detail
11.2.2 Haag Streit Business Overview
11.2.3 Haag Streit Ophthalmic Devices and Drugs Introduction
11.2.4 Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.2.5 Haag Streit Recent Development
11.3 Topcon
11.3.1 Topcon Company Detail
11.3.2 Topcon Business Overview
11.3.3 Topcon Ophthalmic Devices and Drugs Introduction
11.3.4 Topcon Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.3.5 Topcon Recent Development
11.4 Nidek
11.4.1 Nidek Company Detail
11.4.2 Nidek Business Overview
11.4.3 Nidek Ophthalmic Devices and Drugs Introduction
11.4.4 Nidek Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.4.5 Nidek Recent Development
11.5 Essilor
11.5.1 Essilor Company Detail
11.5.2 Essilor Business Overview
11.5.3 Essilor Ophthalmic Devices and Drugs Introduction
11.5.4 Essilor Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.5.5 Essilor Recent Development
11.6 Ziemer
11.6.1 Ziemer Company Detail
11.6.2 Ziemer Business Overview
11.6.3 Ziemer Ophthalmic Devices and Drugs Introduction
11.6.4 Ziemer Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.6.5 Ziemer Recent Development
11.7 Canon
11.7.1 Canon Company Detail
11.7.2 Canon Business Overview
11.7.3 Canon Ophthalmic Devices and Drugs Introduction
11.7.4 Canon Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.7.5 Canon Recent Development
11.8 Gulden Ophthalmics
11.8.1 Gulden Ophthalmics Company Detail
11.8.2 Gulden Ophthalmics Business Overview
11.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Introduction
11.8.4 Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.8.5 Gulden Ophthalmics Recent Development
11.9 Optovue
11.9.1 Optovue Company Detail
11.9.2 Optovue Business Overview
11.9.3 Optovue Ophthalmic Devices and Drugs Introduction
11.9.4 Optovue Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.9.5 Optovue Recent Development
11.10 Quest Medical
11.10.1 Quest Medical Company Detail
11.10.2 Quest Medical Business Overview
11.10.3 Quest Medical Ophthalmic Devices and Drugs Introduction
11.10.4 Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.10.5 Quest Medical Recent Development
11.11 Phoenix DeVentures
11.11.1 Phoenix DeVentures Company Detail
11.11.2 Phoenix DeVentures Business Overview
11.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Introduction
11.11.4 Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.11.5 Phoenix DeVentures Recent Development
11.12 EyeKon Medical
11.12.1 EyeKon Medical Company Detail
11.12.2 EyeKon Medical Business Overview
11.12.3 EyeKon Medical Ophthalmic Devices and Drugs Introduction
11.12.4 EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.12.5 EyeKon Medical Recent Development
11.13 FCI Ophthalmics
11.13.1 FCI Ophthalmics Company Detail
11.13.2 FCI Ophthalmics Business Overview
11.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Introduction
11.13.4 FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.13.5 FCI Ophthalmics Recent Development
11.14 Atrion
11.14.1 Atrion Company Detail
11.14.2 Atrion Business Overview
11.14.3 Atrion Ophthalmic Devices and Drugs Introduction
11.14.4 Atrion Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.14.5 Atrion Recent Development
11.15 Sterimedix
11.15.1 Sterimedix Company Detail
11.15.2 Sterimedix Business Overview
11.15.3 Sterimedix Ophthalmic Devices and Drugs Introduction
11.15.4 Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.15.5 Sterimedix Recent Development
11.16 OPIA
11.16.1 OPIA Company Detail
11.16.2 OPIA Business Overview
11.16.3 OPIA Ophthalmic Devices and Drugs Introduction
11.16.4 OPIA Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.16.5 OPIA Recent Development
11.17 IRIDEX
11.17.1 IRIDEX Company Detail
11.17.2 IRIDEX Business Overview
11.17.3 IRIDEX Ophthalmic Devices and Drugs Introduction
11.17.4 IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.17.5 IRIDEX Recent Development
11.18 Jardon Eye Prosthetics
11.18.1 Jardon Eye Prosthetics Company Detail
11.18.2 Jardon Eye Prosthetics Business Overview
11.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Introduction
11.18.4 Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.18.5 Jardon Eye Prosthetics Recent Development
11.19 Santen Pharmaceutical
11.19.1 Santen Pharmaceutical Company Detail
11.19.2 Santen Pharmaceutical Business Overview
11.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Introduction
11.19.4 Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.19.5 Santen Pharmaceutical Recent Development
11.20 Bausch Health
11.20.1 Bausch Health Company Detail
11.20.2 Bausch Health Business Overview
11.20.3 Bausch Health Ophthalmic Devices and Drugs Introduction
11.20.4 Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.20.5 Bausch Health Recent Development
11.21 Takeda
11.21.1 Takeda Company Detail
11.21.2 Takeda Business Overview
11.21.3 Takeda Ophthalmic Devices and Drugs Introduction
11.21.4 Takeda Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.21.5 Takeda Recent Development
11.22 Novartis
11.22.1 Novartis Company Detail
11.22.2 Novartis Business Overview
11.22.3 Novartis Ophthalmic Devices and Drugs Introduction
11.22.4 Novartis Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.22.5 Novartis Recent Development
11.23 Genentech
11.23.1 Genentech Company Detail
11.23.2 Genentech Business Overview
11.23.3 Genentech Ophthalmic Devices and Drugs Introduction
11.23.4 Genentech Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.23.5 Genentech Recent Development
11.24 Allergan
11.24.1 Allergan Company Detail
11.24.2 Allergan Business Overview
11.24.3 Allergan Ophthalmic Devices and Drugs Introduction
11.24.4 Allergan Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.24.5 Allergan Recent Development
11.25 Sun Pharmaceutical Industries
11.25.1 Sun Pharmaceutical Industries Company Detail
11.25.2 Sun Pharmaceutical Industries Business Overview
11.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Introduction
11.25.4 Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.25.5 Sun Pharmaceutical Industries Recent Development
11.26 Actavis Generics
11.26.1 Actavis Generics Company Detail
11.26.2 Actavis Generics Business Overview
11.26.3 Actavis Generics Ophthalmic Devices and Drugs Introduction
11.26.4 Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.26.5 Actavis Generics Recent Development
11.27 Regeneron Pharmaceuticals
11.27.1 Regeneron Pharmaceuticals Company Detail
11.27.2 Regeneron Pharmaceuticals Business Overview
11.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Introduction
11.27.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.27.5 Regeneron Pharmaceuticals Recent Development
11.28 Pfizer
11.28.1 Pfizer Company Detail
11.28.2 Pfizer Business Overview
11.28.3 Pfizer Ophthalmic Devices and Drugs Introduction
11.28.4 Pfizer Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.28.5 Pfizer Recent Development
11.29 Johnson and Johnson
11.29.1 Johnson and Johnson Company Detail
11.29.2 Johnson and Johnson Business Overview
11.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Introduction
11.29.4 Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.29.5 Johnson and Johnson Recent Development
11.30 Bausch and Lomb
11.30.1 Bausch and Lomb Company Detail
11.30.2 Bausch and Lomb Business Overview
11.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Introduction
11.30.4 Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2018-2023)
11.30.5 Bausch and Lomb Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details